Results 41 to 50 of about 9,425 (219)

A Portable Colorimetric Device for Rapid Bacterial Detection with Cleavable Functional Nucleic Acid Probes for A Common Bacterial Endoribonuclease

Angewandte Chemie, EarlyView.
A simple, rapid, and portable gold‐coated filter tip‐based assay (GFTA) is developed for bacterial detection. The GFTA leverages cleavable functional nucleic acid probes as molecular recognition elements to target RNase H2, a highly conserved bacterial endoribonuclease, enabling sensitive and specific colorimetric detection of bacterial pathogens ...
Jiuxing Li, Rudi Liu, Wenqing Zhang, Bruno J. Salena, Yingfu Li   +4 more
wiley   +2 more sources

Point of care testing to monitor INR control in patients with antiphospholipid syndrome

eJHaem, 2022
Patients with antiphospholipid syndrome (APS) typically require lifelong warfarin anticoagulation following a thrombotic event due to a significant risk of recurrent thrombosis.
Michael Masucci, Annabelle Li Kam Wa, Emilia Shingleton, Jonathan Martin, Zahra Mahir, Karen Breen   +5 more
doaj   +1 more source

The extended internal QC (eIQC): a new practical approach for quality assurance in point-of-care glucose testing using the POCTopus Software – a pilot study

Journal of Laboratory Medicine, 2020
Quality assurance (QA) in point-of-care testing (POCT) is an important issue for organizing POCT structures within the healthcare sector. In Germany, only one device needs to participate in an external QA program, if the responsible core laboratory is ...
von Meyer Alexander, Luppa Peter B., Cadamuro Janne   +2 more
doaj   +1 more source

Simulation Analysis and Comparison of Point of Care Testing and Central Laboratory Testing

MDM Policy & Practice, 2019
Background. In response to demand for fast and efficient clinical testing, the use of point-of-care testing (POCT) has become increasingly common in the United States.
Reed Harder, Keji Wei, Vikrant Vaze, James E. Stahl   +3 more
doaj   +1 more source

The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial

BMC Health Services Research, 2010
Background While point of care testing (PoCT) for general practitioners is becoming increasingly popular, few studies have investigated whether it represents value for money.
Briggs Nancy E, Moss John R, Laurence Caroline O, Beilby Justin J   +3 more
doaj   +1 more source

Hospital laboratory management in dealing with disaster

Gaceta Sanitaria, 2021
Objective: This study aims to identify scientific evidence and knowledge currently available related to clinical laboratory management in the face of disasters with the literature review method. Method: This is a literature review study.
Rosa Dwi Wahyuni, Syahrir A. Pasinringi, Sukri Palutturi, Muhammad Sabir, Diah Mutiarasari, Miranti, Mariani Rasyid, Haerani Harun, Rahma, Anwar Mallongi, Abd. Farid Lewa   +10 more
doaj   +1 more source

Microfluidic-based point-of-care testing for disease diagnosis [PDF]

E3S Web of Conferences, 2019
The early detection of diseases is important to optimize clinical treatment. To meet the increasing requirement of rapid medical diagnosis, point-of-care testing (POCT) has drawn scientists’ great attention for its outstanding advantages including simple,
Wen Ruixuan
doaj   +1 more source

Use of Point-of-Care Tests (POCTs) by US Primary Care Physicians [PDF]

The Journal of the American Board of Family Medicine, 2016
Point-of-care testing (POCT) has been used in the United States for several decades to diagnose and monitor acute and chronic medical conditions. The aim of this study is to assess the use of POCT and perceived benefits of and concerns regarding POCT among US family physicians.A total of 405 US family physicians responded to an electronic survey about ...
Augustine J, Sohn, John M, Hickner, Fasika, Alem   +2 more
openaire   +2 more sources

Rhinomanometry: point of care test (POCT) for allergic rhinitis in children?

Allergologia et Immunopathologia, 2021
Allergic rhinitis (AR) is a global health problem: its prevalence is 23% in Europe, although it is underestimated because as many as 45% of the cases remain undiagnosed. Globally, almost 500 million people suffer from AR, which shows its increasing incidences.
Velia Malizia, Guiliana Ferrante, Giovanna Cilluffo, Salvatore Fasola, Laura Montalbano, Stefania La Grutta   +5 more
openaire   +2 more sources

Toward Prostate Cancer Early Warning with a Self‐Powered Wearable Biosensing Platform Integrated with Machine Learning

Advanced Science, EarlyView.
ABSTRACT Current prostate cancer detection methods remain limited in non‐invasiveness and specificity, prompting interest in urinary biomarkers such as sarcosine. Here, we report a urine‐powered wearable platform for non‐invasive sarcosine detection as a proof‐of‐concept for decentralized early warning.
Jing Xu, Hanxiao Chen, Qichen Yuan, Liucun Yin, Yifang Tao, Hong Wang, Yuquan Xue, Delai Fu, Huan Pang, Tie Chong, Li Xue   +10 more
wiley   +1 more source